Taxanes: A New Class of Antitumor Agents
The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Abstract
Taxanes belong to a new group of antineoplastic agents with a novel mechanism of action for a cytotoxic drug. They promote microtubule assembly and stabilize the microtubules. Paclitaxel, the first agent in this group to become available, was isolated from the Pacific yew, Taxus brevifolia, in 1971. In preclinical and clinical studies, paclitaxel and its semisynthetic analog docetaxel exhibit significant antitumor activity. This review deals with the physicochemical properties, pharmacology, and results of preclinical and clinical trials of the taxanes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer: Principles and Practice of Oncology.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-819_4 · Cited by 8,516
Wani, M. C., Taylor, H. L., Wall, M. E., Coggon, P., & McPhail, A. T. (1971) · Journal of the American Chemical Society · doi:10.1021/ja00738a045 · Cited by 4,073
Promotion of microtubule assembly in vitro by taxol
SCHIFF, P. B., FANT, J., & HORWITZ, S. B. (1979) · Nature · doi:10.1038/277665a0 · Cited by 3,600
Taxol and Taxane Production by Taxomyces andreanae , an Endophytic Fungus of Pacific Yew
Stierle, A., Strobel, G., & Stierle, D. (1993) · Science · doi:10.1126/science.8097061 · Cited by 1,701
Hypersensitivity reactions from taxol.
Weiss, R. B., Donehower, R. C., Wiernik, P. H., Ohnuma, T., Gralla, R. J., Trump, D. L., Baker, J. R., Van Echo, D. A., Von Hoff, D. D., & Leyland-Jones, B. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.7.1263 · Cited by 1,174
McGuire, W. P., Rowinsky, E. K., Rosenshein, N. B., Grumbine, F. C., Ettinger, D. S., Armstrong, D. K., & Donehower, R. C. (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-111-4-273 · Cited by 1,100
Taxol: A Novel Investigational Antimicrotubule Agent
Rowinsky, E. K., Cazenave, L. A., & Donehower, R. C. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.15.1247 · Cited by 1,090
THE IMPACT OF NATIONAL CANCER ACT
(1991) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/83.24.1797 · Cited by 796
Band Horwitz, S. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90048-b · Cited by 740
Clinical toxicities encountered with paclitaxel (Taxol).
Rowinsky, E. K., Eisenhauer, E. A., Chaudhry, V., Sg, A., & Rc, D. (1993) · PubMed · Cited by 692
Studies With RP 56976 (Taxotere): A Semisynthetic Analogue of Taxol
Ringel, I., & Horwitz, S. B. (1991) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/83.4.288 · Cited by 677
Relationships between the structure of taxol analogs and their antimitotic activity
Gueritte-Voegelein, F., Guenard, D., Lavelle, F., Le Goff, M. T., Mangatal, L., & Potier, P. (1991) · Journal of Medicinal Chemistry · doi:10.1021/jm00107a017 · Cited by 538
Taxol: an antimitotic agent with a new mechanism of action
Manfredi, J. J., & Horwitz, S. B. (1984) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(84)90025-1 · Cited by 483
Experimental antitumor activity of taxotere (RP 56976, NSC 628503), a taxol analogue.
Bissery, M.-C., Guénard, D., Guéritte, F., & Lavelle, F. (1991) · PubMed · Cited by 481
Phase I clinical and pharmacokinetic study of taxol.
Wiernik, P. H., Schwartz, E. L., Strauman, J. J., Dutcher, J. P., Lipton, R. B., & Paietta, E. M. (1987) · PubMed · Cited by 455
Phase II Study of Taxol in Patients With Untreated Advanced Non-Small-Cell Lung Cancer
Murphy, W. K., Fossella, F. V., Winn, R. J., Shin, D. M., Hynes, H. E., Gross, H. M., Davilla, E., Leimert, J., Dhingra, H., Raber, M. N., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.5.384 · Cited by 429
Sequences of taxol and cisplatin: a phase I and pharmacologic study.
Rowinsky, E. K., Gilbert, M. R., McGuire, W. P., Noe, D. A., Grochow, L. B., Forastiere, A. A., Ettinger, D. S., Lubejko, B. G., Clark, B., & Sartorius, S. E. (1991) · Journal of Clinical Oncology · doi:10.1200/jco.1991.9.9.1692 · Cited by 426
Cardiac disturbances during the administration of taxol.
Rowinsky, E. K., McGuire, W. P., Guarnieri, T., Fisherman, J. S., Christian, M. C., & Donehower, R. C. (1991) · Journal of Clinical Oncology · doi:10.1200/jco.1991.9.9.1704 · Cited by 395
Taxol: the first of the taxanes, an important new class of antitumor agents.
Rowinsky, E. K., Onetto-Pothier, N., Canetta, R. M., & Arbuck, S. G. (1992) · PubMed · Cited by 389
De Brabander, M., Geuens, G., Nuydens, R., Willebrords, R., & De Mey, J. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.9.5608 · Cited by 387
Chaudhry, V., Rowinsky, E. K., Sartorius, S. E., Donehower, R. C., & Cornblath, D. R. (1994) · Annals of Neurology · doi:10.1002/ana.410350310 · Cited by 363
Chang, A. Y., Kim, K., Glick, J., Anderson, T., Karp, D., & Johnson, D. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.5.388 · Cited by 336
Phase I trial of intraperitoneal taxol: a Gynecoloic Oncology Group study.
Markman, M., Rowinsky, E., Hakes, T., Reichman, B., Jones, W., Lewis, J. L., Rubin, S., Curtin, J., Barakat, R., & Phillips, M. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.9.1485 · Cited by 313
Huizing, M. T., Keung, A. C., Rosing, H., van der Kuij, V, ten Bokkel Huinink, W. W., Mandjes, I. M., Dubbelman, A. C., Pinedo, H. M., & Beijnen, J. H. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.11.2127 · Cited by 308
Self-citationWiernik, P. H., Schwartz, E. L., Einzig, A., Strauman, J. J., Lipton, R. B., & Dutcher, J. P. (1987) · Journal of Clinical Oncology · doi:10.1200/jco.1987.5.8.1232 · Cited by 275
Postma, T. J., Vermorken, J. B., Liefting, A. J. M., Pinedo, H. M., & Heimans, J. J. (1995) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a059220 · Cited by 271
Self-citationEinzig, A. I., Wiernik, P. H., Sasloff, J., Runowicz, C. D., & Goldberg, G. L. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.11.1748 · Cited by 263
Mathew, A. E., Mejillano, M. R., Nath, J. P., Himes, R. H., & Stella, V. J. (1992) · Journal of Medicinal Chemistry · doi:10.1021/jm00079a019 · Cited by 250
Implications of treadmilling for the stability and polarity of actin and tubulin polymers in vivo.
Kirschner, M. W. (1980) · The Journal of cell biology · doi:10.1083/jcb.86.1.330 · Cited by 240
Reichman, B. S., Seidman, A. D., Crown, J. P., Heelan, R., Hakes, T. B., Lebwohl, D. E., Gilewski, T. A., Surbone, A., Currie, V, & Hudis, C. A. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.10.1943 · Cited by 237
Deutsch, H. M., Glinski, J. A., Hernandez, M., Haugwitz, R. D., Narayanan, V. L., Suffness, M., & Zalkow, L. H. (1989) · Journal of Medicinal Chemistry · doi:10.1021/jm00124a011 · Cited by 221
Lorenz, W., Reimann, H. J., Schmal, A., Dormann, P., Schwarz, B., Neugebauer, E., & Doenicke, A. (1977) · Agents and Actions · doi:10.1007/bf01964882 · Cited by 219
Phase I and pharmacodynamic study of taxol in refractory acute leukemias.
Rowinsky, E. K., Burke, P. J., Karp, J. E., Tucker, R. W., Ettinger, D. S., & Donehower, R. C. (1989) · PubMed · Cited by 196
A reassessment of cardiac toxicity associated with Taxol.
Arbuck, S. G., Strauss, W. H., Rowinsky, E. K., Christian, M. C., Suffness, M., Adams, J., Oakes, M., McGuire, W. P., Reed, E., & Gibbs, H. H. (1993) · PubMed · Cited by 195
Inhibition of neurite initiation and growth by taxol.
Letourneau, P. C., & Ressler, A. H. (1984) · The Journal of cell biology · doi:10.1083/jcb.98.4.1355 · Cited by 195
A handbook of Coniferae and Ginkgoaceae.
Dallimore, W., Jackson, A., & Harrison, S. G. (1966) · Cited by 194
Rowinsky, E. K., Chaudhry, V, Forastiere, A. A., Sartorius, S. E., Ettinger, D. S., Grochow, L. B., Lubejko, B. G., Cornblath, D. R., & Donehower, R. C. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.10.2010 · Cited by 192
An improved synthesis of the taxol side chain and of RP 56976
Denis, J. N., Correa, A., & Greene, A. E. (1990) · The Journal of Organic Chemistry · doi:10.1021/jo00293a052 · Cited by 182
A phase II study of taxol in patients with malignant melanoma
Einzig, A. I., Hochster, H., Wiernik, P. H., Trump, D. L., Dutcher, J. P., Garowski, E., Sasloff, J., & Smith, T. J. (1991) · Investigational New Drugs · doi:10.1007/bf00194546 · Cited by 180
A phase I trial of taxol given by a 6-hour intravenous infusion.
Brown, T., Havlin, K., Weiss, G., Cagnola, J., Koeller, J., Kuhn, J., Rizzo, J., Craig, J., Phillips, J., & Von Hoff, D. (1991) · Journal of Clinical Oncology · doi:10.1200/jco.1991.9.7.1261 · Cited by 180
Sarosy, G., Kohn, E., Stone, D. A., Rothenberg, M., Jacob, J., Adamo, D. O., Ognibene, F. P., Cunnion, R. E., & Reed, E. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.7.1165 · Cited by 179
A phase II trial of taxol in metastatic melanoma
Legha, S. S., Ring, S., Papadopoulos, N., Raber, M., & Benjamin, R. S. (1990) · Cancer · doi:10.1002/1097-0142(19900601)65:11<2478::aid-cncr2820651114>3.0.co;2-s · Cited by 172
Roth, B. J., Loehrer, P. J., Yeap, B. Y., Wilding, G., Kasimis, B. S., & McLeod, D. G. (1993) · Cancer · doi:10.1002/1097-0142(19931015)72:8<2457::aid-cncr2820720825>3.0.co;2-z · Cited by 168
Direct Photoaffinity Labeling of Tubulin With Taxol
Rao, S., Horwitz, S. B., & Ringel, I. (1992) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/84.10.785 · Cited by 156
Phase I Trial of Taxotere: Five-Day Schedule
Pazdur, R., Newman, R. A., Newman, B. M., Fuentes, A., Benvenuto, J. A., Bready, B., Moore, D., Jaiyesimi, I. A., Vreeland, F., Bayssas, M., et al. (1992) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/84.23.1781 · Cited by 134
Phase I clinical trial of taxotere administered as either a 2-hour or 6-hour intravenous infusion.
Burris, H. A., Irvin, R. J., Kuhn, J. G., Kalter, S., Smith, L., Shaffer, D. W., Jones, S. F., Weiss, G. R., Eckardt, J. R., & Rodriguez, G. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.5.950 · Cited by 133
Synergistic interaction between cisplatin and taxol in human ovarian carcinoma cells in vitro
Jekunen, A., Christen, R., Shalinsky, D., & Howell, S. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.55 · Cited by 128
Waugh, W. N., Trissel, L. A., & Stella, V. J. (1991) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/48.7.1520 · Cited by 124
Taxol metabolism. Isolation and identification of three major metabolites of taxol in rat bile.
Monsarrat, B., Mariel, E., CROS, S., Garès, M., Guénard, D., Guéritte, F., & Wright, M. (1990) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08688-x · Cited by 115
Longnecker, S. M., Donehower, R. C., Cates, A. E., Chen, T. L., Brundrett, R. B., Grochow, L. B., Ettinger, D. S., & Colvin, M. (1987) · PubMed · Cited by 112
Phase I study of taxol administered as a short i.v. infusion daily for 5 days.
Grem, J. L., Tutsch, K. D., Simon, K., Alberti, D. B., Willson, J. K. V., Tormey, D. C., Swaminathan, S., & Trump, D. L. (1987) · PubMed · Cited by 102
HPLC Separation of Taxol and Cephalomannine
Cardellina, J. H. (1991) · Journal of Liquid Chromatography · doi:10.1080/01483919108049278 · Cited by 101
Preparation and biological activity of taxol acetates
Mellado, W., Magri, N. F., Kingston, D. G. I., Garcia‐Arenas, R., Orr, G. A., & Horwitz, S. B. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(84)91557-2 · Cited by 99
Microtubule arrays in taxol-treated mouse dorsal root ganglion-spinal cord cultures
Masurovsky, E. B., Peterson, E. R., Crain, S. M., & Horwitz, S. B. (1981) · Brain Research · doi:10.1016/0006-8993(81)90017-2 · Cited by 93
Rowinsky, E. K., Citardi, M. J., Noe, D. A., & Donehower, R. C. (1993) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf01195344 · Cited by 92
Molè-Bajer, J., & Bajer, A. S. (1983) · The Journal of Cell Biology · doi:10.1083/jcb.96.2.527 · Cited by 91
Taxol-induced neuropathy: short-term effects of local injection
R�ytt�, M., Horwitz, S. B., & Raine, C. S. (1984) · Journal of Neurocytology · doi:10.1007/bf01148489 · Cited by 91
Branching of sensory and sympathetic neurites in vitro is inhibited by treatment with taxol
Letourneau, P. C., Shattuck, T. A., & Ressler, A. H. (1986) · Journal of Neuroscience · doi:10.1523/jneurosci.06-07-01912.1986 · Cited by 82
Taxol-induced neuropathy: chronic effects of local injection
Röyttä, M., & Raine, C. S. (1986) · Journal of Neurocytology · doi:10.1007/bf01611731 · Cited by 81
Therapeutic response to taxol of six human tumors xenografted into nude mice
Riondel, J., Jacrot, M., Picot, F., Bériel, H., Mouriquand, C., & Potìer, P. (1986) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00306742 · Cited by 79
Pestalozzi, B. C., Sotos, G. A., Choyke, P. L., Fisherman, J. S., Cowan, K. H., & O’Shaughnessy, J. (1993) · Cancer · doi:10.1002/1097-0142(19930301)71:5<1797::aid-cncr2820710514>3.0.co;2-b · Cited by 77
Masurovsky, E. B., Peterson, E. R., Crain, S. M., & Horwitz, S. B. (1983) · Neuroscience · doi:10.1016/0306-4522(83)90148-3 · Cited by 75
Taxol-induced neuropathy: further ultrastructural studies of nerve fibre changesin situ
R�ytta, M., & Raine, C. S. (1985) · Journal of Neurocytology · doi:10.1007/bf01150269 · Cited by 72
Phase I study of taxol using a 5-day intermittent schedule.
Legha, S. S., Tenney, D. M., & Krakoff, I. R. (1986) · Journal of Clinical Oncology · doi:10.1200/jco.1986.4.5.762 · Cited by 68
Rizzo, J. D., Riley, C. M., Hoff, D. D. V., Kuhn, J. G., Phillips, J. L., & Brown, T. J. (1990) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/0731-7085(90)80023-i · Cited by 64
Jamis‐Dow, C., Klecker, R. W., Sarosy, G., Reed, E., & Collins, J. M. (1993) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00686022 · Cited by 61
Taxol in combination with doxorubicin or etoposide possible antagonism in vitro
Hahn, S. M., Liebmann, J. E., Cook, J. A., Fisher, J. M., Mitchell, J. B., Kaufman, D., Goldspiel, B. R., & Venzon, D. J. (1993) · Cancer · doi:10.1002/1097-0142(19931101)72:9<2705::aid-cncr2820720930>3.0.co;2-k · Cited by 60
Day, B. W., Rezenkran, H. S., Gunsekera, Z. S. P., Loungley, R. E., Lin, M. C., Hamel, E., Kowalski, R. P., & Haa, E. (1996) · Cited by 56
Phase II Trial of Taxol in Patients with Metastatic Renal Cell Carcinoma
Einzig, A. I., Gorowski, E., Sasloff, J., & Wiernik, P. H. (1991) · Cancer Investigation · doi:10.3109/07357909109044223 · Cited by 54
Taxol administered as a 120 hour infusion
Spriggs, D. R., & Tondini, C. A. (1992) · Investigational New Drugs · doi:10.1007/bf00944181 · Cited by 49
Effects of taxol on human neutrophils.
Roberts, R. L., Nath, J., Friedman, M. M., & Gallin, J. I. (1982) · The Journal of Immunology · doi:10.4049/jimmunol.129.5.2134 · Cited by 44
Harvey, S. D., Campbell, J. A., Kelsey, R. G., & Vance, N. C. (1991) · Journal of Chromatography A · doi:10.1016/0021-9673(91)85172-c · Cited by 40
Morphological studies on the effect of taxol on cultured human prostatic cancer cells
Röyttä, M., Laine, K., & Härkönen, P. L. (1987) · The Prostate · doi:10.1002/pros.2990110112 · Cited by 20
From yew to us: the curious development of taxol
Song, J. I. (1991) · JAMA · doi:10.1001/jama.266.9.1281 · Cited by 19
Taxol-induced neuropathy after nerve crush: long-term effects on Schwann and endoneurial cells
Vuorinen, V. S., & R�ytt�, M. (1990) · Acta Neuropathologica · doi:10.1007/bf00294244 · Cited by 19
Taxol-induced neuropathy after nerve crush: long-term effects on regenerating axons
Vuorinen, V. S., & R�ytt�, M. (1990) · Acta Neuropathologica · doi:10.1007/bf00294245 · Cited by 18
Evaluation of New Anticancer Agents Against Human Pancreatic Carcinomas in Nude Mice
Sternberg, C. N., Sordillo, P. P., Cheng, E., Chuang, Y. J., & Niedzwiecki, D. (1987) · American Journal of Clinical Oncology · doi:10.1097/00000421-198706000-00009 · Cited by 13
Cited by
Sparreboom, A., van Asperen, J., Mayer, U., Schinkel, A. H., Smit, J. W., Meijer, D. K. F., Borst, P., Nooijen, W. J., Beijnen, J. H., & van Tellingen, O. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.2031 · Cited by 882
Self-citationIn vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy
Kim, S. C., Kim, D. W., Shim, Y. H., Bang, J. S., Oh, H. S., Kim, S. W., & Seo, M. H. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00275-9 · Cited by 734
Hepatotoxicity of Chemotherapy
King, P. D., & Perry, M. C. (2001) · The Oncologist · doi:10.1634/theoncologist.6-2-162 · Cited by 454
Ruan, G., & Feng, S.-S. (2003) · Biomaterials · doi:10.1016/s0142-9612(03)00419-8 · Cited by 348
Review: Tubulin Function, Action of Antitubulin Drugs, and New Drug Development
Pellegrini, F., & Budman, D. R. (2005) · Cancer Investigation · doi:10.1081/cnv-200055970 · Cited by 313
Metadata
- Authors
- Huizing, M. T., Misser, V. H. S., Pieters, R. C., ten Bokkel Huinink, W. W., Veenhof, C. H. N., Vermorken, J. B., Pinedo, H. M., & Beijnen, J. H.
- Venue
- Cancer Investigation
- Publisher
- Informa UK Limited
- Published
- 1995-01
- Volume
- 13
- Issue
- 4
- Pages
- 381-404
- ISSN
- 0735-7907 (ISSN-L)
- 1532-4192
- OpenAlex
- W2137303860
- Cited by
- 285
- References
- 77
- FWCI
- 3.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.